Qorvo Inc. Stock Slides 7.4%, Underperforms Peers
Dow Jones2026/09/14 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Qorvo Inc. shed 7.4% to $107.98 on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.5% to 7,619.98 and Dow Jones Industrial Average falling 0.3% to 52,421.20.
The stock's fall snapped a five-day winning streak.
Qorvo Inc. closed 10.4% below its 52-week high of $120.52, which the company achieved on September 11th.
The stock underperformed when compared to some of its peers, as Broadcom Inc. fell 4.8% to $344.72, Qualcomm Inc. fell 1.0% to $180.15, and Analog Devices Inc. fell 4.69% to $361.02.
Trading volume totaled 1.8 million, compared to the 50-day average of 1.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
September 14, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage
Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.
2-Yr Benchmark Govt Yields - Germany vs Other Nations
2-Yr Benchmark Govt Yields - U.S. vs Other Nations
10-Yr Benchmark Govt Yields - U.S. vs Other Nations
Crypto prices
More
